How the choice of outerwear for Gregory Bovino, a Border Patrol official, turned into part of the deportation story. By Vanessa Friedman The author has covered political image-making and its ...

The Nike Structure Plus is built to be the softest, springiest stability shoe Nike has ever made, and uses the brand’s ZoomX foam for the first time in a stability shoe. It does achieve its goals in ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...

Add Yahoo as a preferred source to see more of our stories on Google. Every year, copyright expires on intellectual property, releasing more into the public domain where anyone can use it. As time ...

Add Yahoo as a preferred source to see more of our stories on Google. (Image Credit: Marvel Studios) The first Avengers: Doomsday trailer is officially out now, and with it comes a brand new poster ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Astronomers have spotted an intriguing cluster of objects in the Kuiper belt, the enormous, donut-shaped region of icy objects beyond the orbit of Neptune. This latest “inner kernel” was identified by ...

The Senate Agriculture Committee released its own discussion draft market structure bill, addressing digital commodities and how the Commodity Futures Trading Commission might oversee that sector of ...

Forbes contributors publish independent expert analyses and insights. Owen Tedford explains how tech and crypto policies impact the markets. Nov 11, 2025, 09:28am EST Cryptocurrency & Bitcoin on U.S ...

According to a 2024 study from the market research company Talker Research, the average American far exceeds recommended intake levels when it comes to their daily sugar consumption. The survey ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...